Efficient Method Development for Pharmaceutical Impurities

This document is a technical report that discusses the efficient development of analytical methods for pharmaceutical impurities using LabSolutions MD software. The report outlines the importance of controlling pharmaceutical impurities to ensure safety and the necessity for reliable analysis methods. It details the phases of Analytical Quality by Design (AQbD) in method development, including initial screening, optimization, and robustness evaluation. The report presents an example of optimizing the separation of ketoprofen and its impurities by varying mobile phase composition, column oven temperature, and flow rate. It describes how design space visualization aids in evaluating the resolution of compounds and supports robustness assessment across different column lots. The findings indicate that the optimized conditions yield high resolution and robustness, demonstrating the software's capability to streamline method development processes. Additionally, the report highlights the use of matrix views for comparing chromatograms, enhancing the efficiency of identifying optimal analysis conditions.